- Half of the world’s 1,800 clinical studies involving real-world or real-life data since 2006 have been started in the last three years (from 2015-2018), according to a Reuters analysis of the U.S. National Institutes of Health’s clinicaltrials.gov website
- Studying real-world evidence offers manufacturers a powerful tool to prove the value of their drug
- Hot areas for such studies include cancer, heart disease and respiratory disorders
Click here to see the source material
Ben Hirschler. 2018. Big pharma, big data – why drugmakers want your health records. [ONLINE] Available at: https://uk.reuters.com/article/uk-pharmaceuticals-data-analysis/big-pharma-big-data-why-drugmakers-want-your-health-records-idUKKCN1GD4MP. [Accessed 8 January 2019].
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.